TetraLogic Pharmaceuticals Corp (TLOG)

[Ubertino]

Medivir is going into Phase 3 soon but I won't buy the article:

http://adisinsight.springer.com/drugs/800032643


Remetinostat
Alternative Names: SHAPE; SHP-141; SHP-141C; Suberohydroxamic acid phenyl ester (SHAPE)
Latest Information Update: 12 Apr 2017
Price : $50 *
Buy Profile
* Final gross price and currency may vary according to local VAT and billing address.

At a glance
Originator Dana-Farber Cancer Institute; Harvard University
Developer Medivir AB; Shape Pharmaceuticals
Class Antineoplastics; Benzoic acids; Small molecules
Mechanism of Action Histone deacetylase inhibitors
Orphan Drug Status Yes - Cutaneous T cell lymphoma
New Molecular Entity Yes
Highest Development Phases

Phase II Cutaneous T cell lymphoma
Discontinued Plaque psoriasis
Most Recent Events

12 Jun 2017 Stanford University plans a phase II trial for Basal cell cancer in USA (NCT03180528)
07 Apr 2017 Additional efficacy data from a phase II trial in Cutaneous T cell lymphoma released by Medivir
07 Apr 2017 Medivir completes a phase II trial in Cutaneous T cell lymphoma (Early-stage disease) in USA